|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Laboratory of Molecular Physiology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland
Group III metabotropic glutamate receptors (mGluRs; mGluR4, 6, 7, and 8) couple to the G
i/o-containing G protein heterotrimers and act as autoreceptors to regulate glutamate release, probably by inhibiting voltage-gated Ca2+ channels. Although most mGluRs have been functionally expressed in a variety of systems, few studies have demonstrated robust coupling of mGluR8 to downstream effectors. We therefore tested whether activation of mGluR8 inhibited Ca2+ channels. Both L-glutamate (L-Glu) and L-2-amino-4-phosphonobutyric acid (L-AP4), a selective agonist for group III mGluRs, inhibited N-type Ca2+ current in rat superior cervical ganglion neurons previously injected with a cDNA encoding mGluR8a/b. L-AP4 was
100-fold more potent (IC50 = 0.1 µM) than L-Glu (
10 µM), but it had efficacy similar to that of L-Glu (
50% maximal inhibition). The potency and efficacy of L-AP4 and L-Glu were similar for both splice variants. Agonist-induced inhibition was abolished by pretreatment with (R,S)-
-cyclopropyl-4-phosphonophenylglycine, a selective group III mGluR antagonist, and pertussis toxin. Deletion of either a calmodulin (CaM) binding motif in the C terminus or the entire C terminus of mGluR8 did not affect mGluR8-mediated response. Our studies indicate that both mGluR8a and 8b are capable of inhibiting N-type Ca2+ channel, suggesting a role as presynaptic autoreceptors to regulate neuronal excitability. The studies also imply that the potential CaM binding domain is not required for the mGluR8-mediated Ca2+ channel inhibition and the C terminus of mGluR8a is dispensable for receptor coupling to N-type Ca2+ channels.
Address correspondence to: Dr. Stephen R. Ikeda, Laboratory of Molecular Physiology, National Institute on Alcohol Abuse and Alcoholism, Room TS-06, 5625 Fishers Lane, Bethesda, MD 20892-8815. E-mail: sikeda{at}mail.nih.gov
This article has been cited by other articles:
![]() |
C. M. Niswender, K. A. Johnson, C. D. Weaver, C. K. Jones, Z. Xiang, Q. Luo, A. L. Rodriguez, J. E. Marlo, T. de Paulis, A. D. Thompson, et al. Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4 Mol. Pharmacol., November 1, 2008; 74(5): 1345 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Niswender, K. A. Johnson, Q. Luo, J. E. Ayala, C. Kim, P. J. Conn, and C. D. Weaver A Novel Assay of Gi/o-Linked G Protein-Coupled Receptor Coupling to Potassium Channels Provides New Insights into the Pharmacology of the Group III Metabotropic Glutamate Receptors Mol. Pharmacol., April 1, 2008; 73(4): 1213 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, D. J. Williams, H. L. Puhl III, and S. R. Ikeda Inhibition of N-Type Calcium Channels by Activation of GPR35, an Orphan Receptor, Heterologously Expressed in Rat Sympathetic Neurons J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 342 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, H. Chen, H. L. Puhl III, and S. R. Ikeda Fluorophore-assisted light inactivation produces both targeted and collateral effects on N-type calcium channel modulation in rat sympathetic neurons J. Physiol., October 15, 2006; 576(2): 477 - 492. [Abstract] [Full Text] [PDF] |
||||